CDH2 and gastric cancer: As such, the recently discovered anti-tumor compound salidroside was found to increase the E-cadherin/N-cadherin ratio and inhibit proliferation, migration, and invasion of gastric cancer cells by downregulating the Src-associated signaling pathway and Hsp70 expression [38].